Benzinga's Top #PreMarket Gainers
October 22, 2014 at 08:34 AM EDT
Regulus Therapeutics (NASDAQ: RGLS) shares jumped 62.33% to $10.99 in pre-market trading following the announcement of positive RG-101 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.